{
  "pmcid": "7687276",
  "sha256": "a415fd2a752ad95332635c2b87fac8ca72da4d933906d9a44b7b61ab3cf68269",
  "timestamp_utc": "2025-11-10T00:07:10.277587+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 11.84771341463415,
    "reading_ease": 37.50498475609757,
    "word_count": 246
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Cost-Effectiveness of Primary Anastomosis versus Hartmann's Procedure for Perforated Diverticulitis: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomly assigned to PA or HP in a 1:1 ratio following diagnostic laparoscopy."
      },
      "Participants": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomly assigned to PA or HP in a 1:1 ratio following diagnostic laparoscopy."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to assess the cost-effectiveness of primary anastomosis (PA) compared to Hartmann's procedure (HP) for treating Hinchey grade III or IV diverticulitis."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was 12-month stoma-free survival."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Randomisation was centrally managed, and allocation was not concealed."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not applied."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 130 patients were randomised between July 2010 and June 2016, with 64 allocated to PA and 66 to HP."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Analysis was conducted using a modified intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Mean costs per patient were lower for PA (€20,544, 95% CI 19,569 to 21,519) compared to HP (€28,670, 95% CI 26,636 to 30,704), with a mean difference of €–8,126 (95% CI –14,660 to –1,592)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No significant adverse events were reported."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "The trial was registered at trialregister.nl (NTR2037) and ClinicalTrials.gov (NCT01317485)."
      },
      "Funding": {
        "score": 1,
        "evidence": "Funding was provided by the Dutch National Health Care Institute."
      }
    },
    "total_score": 17,
    "max_score": 25
  }
}